Global Hormonal Implants Market

Hormonal Implants Comprehensive Study by Type (Levonorgestrel Hormonal Implants, Etonogestrel Hormonal Implants), Application (Hospitals, Clinics, Others) Players and Region - Global Market Outlook to 2024

Hormonal Implants Market by XX Submarkets | Forecast Years 2022-2027  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Global Hormonal Implants Market Overview:
Hormonal implants are referred to as a type of birth control present in the shape of a tiny tube which is placed under the skin of the upper arm of a woman. The Hormonal Implants prevents pregnancy and it is been effective for 3 years. The implant looks like the size of a toothpick and it is made of a flexible plastic which contains a type of medicine that is progestin hormone called etonogestrel. The market of the hormonal implant is rising due to the rising preferences about Increasing need for population control and increasing incident of abortion, while some of the factors like side effects and growing occurrence of infertility amongst women is further restricting the use of hormonal implants. Some of the key players profiled in the study are Bayer HealthCare (Germany), Merck (United States), Shanghai Dahua Pharmaceuticals (China), Mayo Clinic Hospital (United States), HowuKnow (Malaysia), Allergan (Ireland), Medical Xpress (Isle of Man), NHS (United Kingdom), Sexwise (United Kingdom) and Planned Parenthood (United States).

On the basis of geography, the market of Hormonal Implants has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).

Market Drivers
  • Increasing need of population control and increasing incident of abortion
  • Governmental initiatives for minimizing unwanted pregnancy
  • High incident rate of unintended pregnancies is leading to unmet hormonal implants needs

Market Trend
  • Increasingly causing working-class women to postpone pregnancy in both developed and developing economies

Restraints
  • The side effects associated with the use of hormonal implants

Opportunities
  • Ethical and social issues restrict the use of subsidies on hormonal implants in some countries
  • Presence of large hormonal implants needs in emerging Asian and African countries

Challenges
  • Rising occurrence of infertility amongst women is restricting the use of hormonal implants
  • Social and ethical issues are expected to restrict the use of birth control activity in the near future




The global hormonal implants market is new competitive and consists of some key players. In terms of market share, few of the key players presently dominate the global market who are already in the contraceptive segment. And those players are acquiring small players to make their footprint stable in this market.

Target Audience:
Venture Capitalists and Private Equity Firms, New Entrants/Investors, Analysts and Strategic Business Planners, Manufacturers, Suppliers and Distributors, Raw Material Suppliers, Government Regulatory and Research Organizations and End-Use Industries

Major Objectives Focused through this Study
• To define, describe, and forecast the Global Hormonal Implants market on the basis of product [Levonorgestrel Hormonal Implants and Etonogestrel Hormonal Implants] , application [Hospitals, Clinics and Others], key regions and end user
• To provide in-depth information regarding major influencing factors affecting the growth of the market (trends, drivers, restraints, opportunities, and industry-centric and regional challenges)
• To strategically analyse the micro-markets and important business segments with respect to individual growth drivers , market trends and potential, and historical contributions to the total market
• Identifying the opportunities in the market for key stakeholders and detailing the competitive landscape for market leaders
• To provide market size for various segments of the Hormonal Implants market with respect to major geographies, namely, South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico)
• To strategically profile the key players and analyzing their market shares and core competencies in the Hormonal Implants industry
• To track key developments such as product launches, expansions, agreements, partnerships, mergers & acquisitions, and R&D activities that are key factors in shaping the market

Available Customization:
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**. Additionally, the Players which are also part of the research are .
** Confirmation on availability of data would be informed prior purchase

While framing the research framework, major and emerging players operating in the Hormonal Implants market in various regions have been profiled, and their offerings, geographic footprints, and distribution/sales channels have been analysed through in-depth discussions. Top-down and bottom-up approaches have been used to determine the overall market size. Sizes of the other individual markets have been estimated using the percentage splits obtained through secondary sources such as Hoovers, Bloomberg BusinessWeek, and Dow Jones (Factiva), along with primary respondents. The complete methodology includes the study of the annual and financial reports of the key market players and extensive interviews with industry experts such as CEOs, VPs, directors, and marketing executives for key insights (both qualitative and quantitative) related to the market.

Report Objectives / Segmentation Covered

By Type
  • Levonorgestrel Hormonal Implants
  • Etonogestrel Hormonal Implants
By Application
  • Hospitals
  • Clinics
  • Others
By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing need of population control and increasing incident of abortion
      • 3.2.2. Governmental initiatives for minimizing unwanted pregnancy
      • 3.2.3. High incident rate of unintended pregnancies is leading to unmet hormonal implants needs
    • 3.3. Market Challenges
      • 3.3.1. Rising occurrence of infertility amongst women is restricting the use of hormonal implants
      • 3.3.2. Social and ethical issues are expected to restrict the use of birth control activity in the near future
    • 3.4. Market Trends
      • 3.4.1. Increasingly causing working-class women to postpone pregnancy in both developed and developing economies
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Hormonal Implants, by Type, Application and Region (value) (2013-2018)
    • 5.1. Introduction
    • 5.2. Global Hormonal Implants (Value)
      • 5.2.1. Global Hormonal Implants by: Type (Value)
        • 5.2.1.1. Levonorgestrel Hormonal Implants
        • 5.2.1.2. Etonogestrel Hormonal Implants
      • 5.2.2. Global Hormonal Implants by: Application (Value)
        • 5.2.2.1. Hospitals
        • 5.2.2.2. Clinics
        • 5.2.2.3. Others
      • 5.2.3. Global Hormonal Implants Region
        • 5.2.3.1. South America
          • 5.2.3.1.1. Brazil
          • 5.2.3.1.2. Argentina
          • 5.2.3.1.3. Rest of South America
        • 5.2.3.2. Asia Pacific
          • 5.2.3.2.1. China
          • 5.2.3.2.2. Japan
          • 5.2.3.2.3. India
          • 5.2.3.2.4. South Korea
          • 5.2.3.2.5. Taiwan
          • 5.2.3.2.6. Australia
          • 5.2.3.2.7. Rest of Asia-Pacific
        • 5.2.3.3. Europe
          • 5.2.3.3.1. Germany
          • 5.2.3.3.2. France
          • 5.2.3.3.3. Italy
          • 5.2.3.3.4. United Kingdom
          • 5.2.3.3.5. Netherlands
          • 5.2.3.3.6. Rest of Europe
        • 5.2.3.4. MEA
          • 5.2.3.4.1. Middle East
          • 5.2.3.4.2. Africa
        • 5.2.3.5. North America
          • 5.2.3.5.1. United States
          • 5.2.3.5.2. Canada
          • 5.2.3.5.3. Mexico
  • 6. Hormonal Implants: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2018)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Bayer HealthCare (Germany)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Merck (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Shanghai Dahua Pharmaceuticals (China)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Mayo Clinic Hospital (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. HowuKnow (Malaysia)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Allergan (Ireland)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Medical Xpress (Isle of Man)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. NHS (United Kingdom)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Sexwise (United Kingdom)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Planned Parenthood (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Hormonal Implants Sale, by Type, Application and Region (value) (2019-2024)
    • 7.1. Introduction
    • 7.2. Global Hormonal Implants (Value)
      • 7.2.1. Global Hormonal Implants by: Type (Value)
        • 7.2.1.1. Levonorgestrel Hormonal Implants
        • 7.2.1.2. Etonogestrel Hormonal Implants
      • 7.2.2. Global Hormonal Implants by: Application (Value)
        • 7.2.2.1. Hospitals
        • 7.2.2.2. Clinics
        • 7.2.2.3. Others
      • 7.2.3. Global Hormonal Implants Region
        • 7.2.3.1. South America
          • 7.2.3.1.1. Brazil
          • 7.2.3.1.2. Argentina
          • 7.2.3.1.3. Rest of South America
        • 7.2.3.2. Asia Pacific
          • 7.2.3.2.1. China
          • 7.2.3.2.2. Japan
          • 7.2.3.2.3. India
          • 7.2.3.2.4. South Korea
          • 7.2.3.2.5. Taiwan
          • 7.2.3.2.6. Australia
          • 7.2.3.2.7. Rest of Asia-Pacific
        • 7.2.3.3. Europe
          • 7.2.3.3.1. Germany
          • 7.2.3.3.2. France
          • 7.2.3.3.3. Italy
          • 7.2.3.3.4. United Kingdom
          • 7.2.3.3.5. Netherlands
          • 7.2.3.3.6. Rest of Europe
        • 7.2.3.4. MEA
          • 7.2.3.4.1. Middle East
          • 7.2.3.4.2. Africa
        • 7.2.3.5. North America
          • 7.2.3.5.1. United States
          • 7.2.3.5.2. Canada
          • 7.2.3.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Hormonal Implants: by Type(USD Million)
  • Table 2. Hormonal Implants Levonorgestrel Hormonal Implants , by Region USD Million (2013-2018)
  • Table 3. Hormonal Implants Etonogestrel Hormonal Implants , by Region USD Million (2013-2018)
  • Table 4. Hormonal Implants: by Application(USD Million)
  • Table 5. Hormonal Implants Hospitals , by Region USD Million (2013-2018)
  • Table 6. Hormonal Implants Clinics , by Region USD Million (2013-2018)
  • Table 7. Hormonal Implants Others , by Region USD Million (2013-2018)
  • Table 8. South America Hormonal Implants, by Country USD Million (2013-2018)
  • Table 9. South America Hormonal Implants, by Type USD Million (2013-2018)
  • Table 10. South America Hormonal Implants, by Application USD Million (2013-2018)
  • Table 11. Brazil Hormonal Implants, by Type USD Million (2013-2018)
  • Table 12. Brazil Hormonal Implants, by Application USD Million (2013-2018)
  • Table 13. Argentina Hormonal Implants, by Type USD Million (2013-2018)
  • Table 14. Argentina Hormonal Implants, by Application USD Million (2013-2018)
  • Table 15. Rest of South America Hormonal Implants, by Type USD Million (2013-2018)
  • Table 16. Rest of South America Hormonal Implants, by Application USD Million (2013-2018)
  • Table 17. Asia Pacific Hormonal Implants, by Country USD Million (2013-2018)
  • Table 18. Asia Pacific Hormonal Implants, by Type USD Million (2013-2018)
  • Table 19. Asia Pacific Hormonal Implants, by Application USD Million (2013-2018)
  • Table 20. China Hormonal Implants, by Type USD Million (2013-2018)
  • Table 21. China Hormonal Implants, by Application USD Million (2013-2018)
  • Table 22. Japan Hormonal Implants, by Type USD Million (2013-2018)
  • Table 23. Japan Hormonal Implants, by Application USD Million (2013-2018)
  • Table 24. India Hormonal Implants, by Type USD Million (2013-2018)
  • Table 25. India Hormonal Implants, by Application USD Million (2013-2018)
  • Table 26. South Korea Hormonal Implants, by Type USD Million (2013-2018)
  • Table 27. South Korea Hormonal Implants, by Application USD Million (2013-2018)
  • Table 28. Taiwan Hormonal Implants, by Type USD Million (2013-2018)
  • Table 29. Taiwan Hormonal Implants, by Application USD Million (2013-2018)
  • Table 30. Australia Hormonal Implants, by Type USD Million (2013-2018)
  • Table 31. Australia Hormonal Implants, by Application USD Million (2013-2018)
  • Table 32. Rest of Asia-Pacific Hormonal Implants, by Type USD Million (2013-2018)
  • Table 33. Rest of Asia-Pacific Hormonal Implants, by Application USD Million (2013-2018)
  • Table 34. Europe Hormonal Implants, by Country USD Million (2013-2018)
  • Table 35. Europe Hormonal Implants, by Type USD Million (2013-2018)
  • Table 36. Europe Hormonal Implants, by Application USD Million (2013-2018)
  • Table 37. Germany Hormonal Implants, by Type USD Million (2013-2018)
  • Table 38. Germany Hormonal Implants, by Application USD Million (2013-2018)
  • Table 39. France Hormonal Implants, by Type USD Million (2013-2018)
  • Table 40. France Hormonal Implants, by Application USD Million (2013-2018)
  • Table 41. Italy Hormonal Implants, by Type USD Million (2013-2018)
  • Table 42. Italy Hormonal Implants, by Application USD Million (2013-2018)
  • Table 43. United Kingdom Hormonal Implants, by Type USD Million (2013-2018)
  • Table 44. United Kingdom Hormonal Implants, by Application USD Million (2013-2018)
  • Table 45. Netherlands Hormonal Implants, by Type USD Million (2013-2018)
  • Table 46. Netherlands Hormonal Implants, by Application USD Million (2013-2018)
  • Table 47. Rest of Europe Hormonal Implants, by Type USD Million (2013-2018)
  • Table 48. Rest of Europe Hormonal Implants, by Application USD Million (2013-2018)
  • Table 49. MEA Hormonal Implants, by Country USD Million (2013-2018)
  • Table 50. MEA Hormonal Implants, by Type USD Million (2013-2018)
  • Table 51. MEA Hormonal Implants, by Application USD Million (2013-2018)
  • Table 52. Middle East Hormonal Implants, by Type USD Million (2013-2018)
  • Table 53. Middle East Hormonal Implants, by Application USD Million (2013-2018)
  • Table 54. Africa Hormonal Implants, by Type USD Million (2013-2018)
  • Table 55. Africa Hormonal Implants, by Application USD Million (2013-2018)
  • Table 56. North America Hormonal Implants, by Country USD Million (2013-2018)
  • Table 57. North America Hormonal Implants, by Type USD Million (2013-2018)
  • Table 58. North America Hormonal Implants, by Application USD Million (2013-2018)
  • Table 59. United States Hormonal Implants, by Type USD Million (2013-2018)
  • Table 60. United States Hormonal Implants, by Application USD Million (2013-2018)
  • Table 61. Canada Hormonal Implants, by Type USD Million (2013-2018)
  • Table 62. Canada Hormonal Implants, by Application USD Million (2013-2018)
  • Table 63. Mexico Hormonal Implants, by Type USD Million (2013-2018)
  • Table 64. Mexico Hormonal Implants, by Application USD Million (2013-2018)
  • Table 65. Company Basic Information, Sales Area and Its Competitors
  • Table 66. Company Basic Information, Sales Area and Its Competitors
  • Table 67. Company Basic Information, Sales Area and Its Competitors
  • Table 68. Company Basic Information, Sales Area and Its Competitors
  • Table 69. Company Basic Information, Sales Area and Its Competitors
  • Table 70. Company Basic Information, Sales Area and Its Competitors
  • Table 71. Company Basic Information, Sales Area and Its Competitors
  • Table 72. Company Basic Information, Sales Area and Its Competitors
  • Table 73. Company Basic Information, Sales Area and Its Competitors
  • Table 74. Company Basic Information, Sales Area and Its Competitors
  • Table 75. Hormonal Implants: by Type(USD Million)
  • Table 76. Hormonal Implants Levonorgestrel Hormonal Implants , by Region USD Million (2019-2024)
  • Table 77. Hormonal Implants Etonogestrel Hormonal Implants , by Region USD Million (2019-2024)
  • Table 78. Hormonal Implants: by Application(USD Million)
  • Table 79. Hormonal Implants Hospitals , by Region USD Million (2019-2024)
  • Table 80. Hormonal Implants Clinics , by Region USD Million (2019-2024)
  • Table 81. Hormonal Implants Others , by Region USD Million (2019-2024)
  • Table 82. South America Hormonal Implants, by Country USD Million (2019-2024)
  • Table 83. South America Hormonal Implants, by Type USD Million (2019-2024)
  • Table 84. South America Hormonal Implants, by Application USD Million (2019-2024)
  • Table 85. Brazil Hormonal Implants, by Type USD Million (2019-2024)
  • Table 86. Brazil Hormonal Implants, by Application USD Million (2019-2024)
  • Table 87. Argentina Hormonal Implants, by Type USD Million (2019-2024)
  • Table 88. Argentina Hormonal Implants, by Application USD Million (2019-2024)
  • Table 89. Rest of South America Hormonal Implants, by Type USD Million (2019-2024)
  • Table 90. Rest of South America Hormonal Implants, by Application USD Million (2019-2024)
  • Table 91. Asia Pacific Hormonal Implants, by Country USD Million (2019-2024)
  • Table 92. Asia Pacific Hormonal Implants, by Type USD Million (2019-2024)
  • Table 93. Asia Pacific Hormonal Implants, by Application USD Million (2019-2024)
  • Table 94. China Hormonal Implants, by Type USD Million (2019-2024)
  • Table 95. China Hormonal Implants, by Application USD Million (2019-2024)
  • Table 96. Japan Hormonal Implants, by Type USD Million (2019-2024)
  • Table 97. Japan Hormonal Implants, by Application USD Million (2019-2024)
  • Table 98. India Hormonal Implants, by Type USD Million (2019-2024)
  • Table 99. India Hormonal Implants, by Application USD Million (2019-2024)
  • Table 100. South Korea Hormonal Implants, by Type USD Million (2019-2024)
  • Table 101. South Korea Hormonal Implants, by Application USD Million (2019-2024)
  • Table 102. Taiwan Hormonal Implants, by Type USD Million (2019-2024)
  • Table 103. Taiwan Hormonal Implants, by Application USD Million (2019-2024)
  • Table 104. Australia Hormonal Implants, by Type USD Million (2019-2024)
  • Table 105. Australia Hormonal Implants, by Application USD Million (2019-2024)
  • Table 106. Rest of Asia-Pacific Hormonal Implants, by Type USD Million (2019-2024)
  • Table 107. Rest of Asia-Pacific Hormonal Implants, by Application USD Million (2019-2024)
  • Table 108. Europe Hormonal Implants, by Country USD Million (2019-2024)
  • Table 109. Europe Hormonal Implants, by Type USD Million (2019-2024)
  • Table 110. Europe Hormonal Implants, by Application USD Million (2019-2024)
  • Table 111. Germany Hormonal Implants, by Type USD Million (2019-2024)
  • Table 112. Germany Hormonal Implants, by Application USD Million (2019-2024)
  • Table 113. France Hormonal Implants, by Type USD Million (2019-2024)
  • Table 114. France Hormonal Implants, by Application USD Million (2019-2024)
  • Table 115. Italy Hormonal Implants, by Type USD Million (2019-2024)
  • Table 116. Italy Hormonal Implants, by Application USD Million (2019-2024)
  • Table 117. United Kingdom Hormonal Implants, by Type USD Million (2019-2024)
  • Table 118. United Kingdom Hormonal Implants, by Application USD Million (2019-2024)
  • Table 119. Netherlands Hormonal Implants, by Type USD Million (2019-2024)
  • Table 120. Netherlands Hormonal Implants, by Application USD Million (2019-2024)
  • Table 121. Rest of Europe Hormonal Implants, by Type USD Million (2019-2024)
  • Table 122. Rest of Europe Hormonal Implants, by Application USD Million (2019-2024)
  • Table 123. MEA Hormonal Implants, by Country USD Million (2019-2024)
  • Table 124. MEA Hormonal Implants, by Type USD Million (2019-2024)
  • Table 125. MEA Hormonal Implants, by Application USD Million (2019-2024)
  • Table 126. Middle East Hormonal Implants, by Type USD Million (2019-2024)
  • Table 127. Middle East Hormonal Implants, by Application USD Million (2019-2024)
  • Table 128. Africa Hormonal Implants, by Type USD Million (2019-2024)
  • Table 129. Africa Hormonal Implants, by Application USD Million (2019-2024)
  • Table 130. North America Hormonal Implants, by Country USD Million (2019-2024)
  • Table 131. North America Hormonal Implants, by Type USD Million (2019-2024)
  • Table 132. North America Hormonal Implants, by Application USD Million (2019-2024)
  • Table 133. United States Hormonal Implants, by Type USD Million (2019-2024)
  • Table 134. United States Hormonal Implants, by Application USD Million (2019-2024)
  • Table 135. Canada Hormonal Implants, by Type USD Million (2019-2024)
  • Table 136. Canada Hormonal Implants, by Application USD Million (2019-2024)
  • Table 137. Mexico Hormonal Implants, by Type USD Million (2019-2024)
  • Table 138. Mexico Hormonal Implants, by Application USD Million (2019-2024)
  • Table 139. Research Programs/Design for This Report
  • Table 140. Key Data Information from Secondary Sources
  • Table 141. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Hormonal Implants: by Type USD Million (2013-2018)
  • Figure 5. Global Hormonal Implants: by Application USD Million (2013-2018)
  • Figure 6. South America Hormonal Implants Share (%), by Country
  • Figure 7. Asia Pacific Hormonal Implants Share (%), by Country
  • Figure 8. Europe Hormonal Implants Share (%), by Country
  • Figure 9. MEA Hormonal Implants Share (%), by Country
  • Figure 10. North America Hormonal Implants Share (%), by Country
  • Figure 11. Global Hormonal Implants share by Players 2018 (%)
  • Figure 12. Global Hormonal Implants share by Players (Top 3) 2018(%)
  • Figure 13. Global Hormonal Implants share by Players (Top 5) 2018(%)
  • Figure 14. BCG Matrix for key Companies
  • Figure 15. Bayer HealthCare (Germany) Revenue, Net Income and Gross profit
  • Figure 16. Bayer HealthCare (Germany) Revenue: by Geography 2018
  • Figure 17. Merck (United States) Revenue, Net Income and Gross profit
  • Figure 18. Merck (United States) Revenue: by Geography 2018
  • Figure 19. Shanghai Dahua Pharmaceuticals (China) Revenue, Net Income and Gross profit
  • Figure 20. Shanghai Dahua Pharmaceuticals (China) Revenue: by Geography 2018
  • Figure 21. Mayo Clinic Hospital (United States) Revenue, Net Income and Gross profit
  • Figure 22. Mayo Clinic Hospital (United States) Revenue: by Geography 2018
  • Figure 23. HowuKnow (Malaysia) Revenue, Net Income and Gross profit
  • Figure 24. HowuKnow (Malaysia) Revenue: by Geography 2018
  • Figure 25. Allergan (Ireland) Revenue, Net Income and Gross profit
  • Figure 26. Allergan (Ireland) Revenue: by Geography 2018
  • Figure 27. Medical Xpress (Isle of Man) Revenue, Net Income and Gross profit
  • Figure 28. Medical Xpress (Isle of Man) Revenue: by Geography 2018
  • Figure 29. NHS (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 30. NHS (United Kingdom) Revenue: by Geography 2018
  • Figure 31. Sexwise (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 32. Sexwise (United Kingdom) Revenue: by Geography 2018
  • Figure 33. Planned Parenthood (United States) Revenue, Net Income and Gross profit
  • Figure 34. Planned Parenthood (United States) Revenue: by Geography 2018
  • Figure 35. Global Hormonal Implants: by Type USD Million (2019-2024)
  • Figure 36. Global Hormonal Implants: by Application USD Million (2019-2024)
  • Figure 37. South America Hormonal Implants Share (%), by Country
  • Figure 38. Asia Pacific Hormonal Implants Share (%), by Country
  • Figure 39. Europe Hormonal Implants Share (%), by Country
  • Figure 40. MEA Hormonal Implants Share (%), by Country
  • Figure 41. North America Hormonal Implants Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Bayer HealthCare (Germany)
  • Merck (United States)
  • Shanghai Dahua Pharmaceuticals (China)
  • Mayo Clinic Hospital (United States)
  • HowuKnow (Malaysia)
  • Allergan (Ireland)
  • Medical Xpress (Isle of Man)
  • NHS (United Kingdom)
  • Sexwise (United Kingdom)
  • Planned Parenthood (United States)
Select User Access Type

Key Highlights of Report


Sep 2019 225 Pages 96 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Hormonal Implants Market Quantitative research analysis
Global Hormonal Implants Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Know More About Global Hormonal Implants Market Report?

Have a Query? Click Here

Other Related Reports

Weight Loss Services Comprehensive Study by Type (Weight Loss Diet (Food, Beverages), Fitness Equipment (Cardiovascular, Strength Training, Infrared Light Therapy, & Others), Surgical Equipment (Bari...
$ 3750
ATP Assay Comprehensive Study by Type (Consumables & Accessories {Reagents & Kits, Microplates, Other Consumables & Accessories}, Instruments {Luminometers, Spectrophotometers}), Application (Contami...
$ 3750
Digestive System Anatomical Model Comprehensive Study by Type (Adult Digestive System Anatomical Model, Children Digestive System Anatomical Model), Application (Hospital & Clinic, Academic Institute...
$ 3650
Dental Fiber Post Comprehensive Study by Type (Tapered, Parallel, Combination), Application (Hospitals, Dental Clinics, Other), Distribution Channel (Online, Offline) Players and Region - Global Mark...
$ 3500
Venipuncture Procedure Analysis Comprehensive Study by Application (Hospital {Public, Private}, Diagnostic Laboratories, Physician Offices/Clinics, Other {Home Care, Long-term Acute Care, Nursing Hom...
$ 3750
Thrombolysis Comprehensive Study by Type (Surgical Treatment, Drug Treatment, Other Treatment), Application (Pulmonary Embolism, Deep Vein Thrombosis, Acute Myocardial Infarction, Blocking the Cathet...
$ 3450